A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Clinical trial NCT07205887 · RECRUITING

Trial details

NCT number: NCT07205887
Sponsor: EyeBiotech Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)

Start date: 2025-09-12
Primary completion: 2028-06-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.